Scholarly Index
Jonathan Corren
APLA Health; 19,359 total citations; 330 total publications; best world rank #27
APLA Health
19,359Total citations
330Total publications
61H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Asthma and respiratory diseases | Lifetime | 265 | US 102 | 99.31 |
| Respiratory and Cough-Related Research | Lifetime | 110 | US 38 | 99.21 |
| Allergic Rhinitis and Sensitization | Lifetime | 176 | US 53 | 99.20 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 227 | US 92 | 98.12 |
| IL-33, ST2, and ILC Pathways | Lifetime | 178 | US 81 | 98.21 |
| Dermatology and Skin Diseases | Lifetime | 362 | US 108 | 98.21 |
| Eosinophilic Esophagitis | Lifetime | 393 | US 150 | 97.99 |
| Pharmaceutical studies and practices | Lifetime | 805 | US 351 | 95.15 |
| Asthma and respiratory diseases | 2021-2025 | 34 | US 10 | 99.51 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 27 | US 10 | 97.73 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 52 | US 15 | 99.11 |
| Respiratory and Cough-Related Research | 2021-2025 | 34 | US 7 | 98.68 |
| Dermatology and Skin Diseases | 2021-2025 | 215 | US 55 | 96.93 |
| Eosinophilic Esophagitis | 2021-2025 | 155 | US 65 | 96.33 |
| Pharmaceutical studies and practices | 2021-2025 | 477 | US 156 | 82.82 |